{"id":946528,"date":"2026-03-24T10:27:31","date_gmt":"2026-03-24T14:27:31","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/envue-medical-expands-presence-within-a-major-michigan-health-system-and-grows-u-s-hospital-footprint-to-39\/"},"modified":"2026-03-24T10:27:31","modified_gmt":"2026-03-24T14:27:31","slug":"envue-medical-expands-presence-within-a-major-michigan-health-system-and-grows-u-s-hospital-footprint-to-39","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/envue-medical-expands-presence-within-a-major-michigan-health-system-and-grows-u-s-hospital-footprint-to-39\/","title":{"rendered":"ENvue Medical Expands Presence within a Major Michigan Health System and Grows U.S. Hospital Footprint to 39"},"content":{"rendered":"

\nPremier 714-bed teaching hospital and Level I Trauma Center purchases ENvue\u2122 Navigation Platform system and feeding tubes
\n<\/h2>\n
\n

TYLER, Texas, March 24, 2026 (GLOBE NEWSWIRE) — ENvue Medical, Inc<\/u><\/a>. (NASDAQ: FEED) (\u201cENvue,\u201d \u201cENvue Medical\u201d or the \u201cCompany\u201d), a medical technology company specializing in the advancement of intelligent, non-invasive solutions for enteral care across clinical and home care settings, today announced a purchase of the ENvue\u2122 Navigation Platform and feeding tubes by a premier teaching hospital and Level I Trauma Center serving the Detroit metropolitan area. The purchase expands ENvue\u2019s presence within a major Southeast Michigan health system where the Company has previously been deployed, and brings ENvue\u2019s U.S. hospital footprint to 39 hospitals.<\/p>\n

The facility is a 714-bed major teaching hospital and a key anchor of a leading regional health system. It is known for comprehensive specialty institutes in oncology, cardiovascular care, and pediatrics, and operates a broad network of critical care environments, including medical, pediatric, surgical, and cardiovascular intensive care units (ICUs), as well as a dedicated Level III Neuro-ICU.<\/p>\n

\u201cWe believe that this partnership represents the strategic account expansion we are focused on nationwide,\u201d said Marc Waldman, Vice President of Commercial at ENvue Medical. \u201cPreeminent teaching and non-teaching hospitals alike are seeking innovative technologies that can improve workflow efficiency while supporting cost containment and patient safety initiatives. The ENvue\u2122 Navigation Platform addresses these priorities, and we are encouraged by the increasing demand we are seeing from health systems looking to modernize, standardize and enhance enteral access procedures across their hospitals.\u201d<\/p>\n

\u201cHospitals are increasingly prioritizing real-time visualization and greater standardization in feeding tube placement,\u201d said Doron Besser, MD, Chief Executive Officer of ENvue Medical. \u201cThis expansion within a leading Michigan health system reflects continued momentum in our commercial execution for the ENvue\u2122 Navigation Platform. We believe we are continuing to build on our relationship within the system as we expand our footprint to 39 hospitals, and we look forward to supporting broader adoption across additional sites over time.\u201d<\/p>\n

ENvue\u2019s Navigation Platform is designed to integrate into existing clinical workflows and is a minimally invasive electromagnetic navigation system intended to assist clinicians in placing feeding tubes into the gastrointestinal tract. FDA 510(k) cleared for adult use, ENvue provides real-time bedside visualization of tube movement and supports informed decision-making during the placement procedure. Future platform expansion may include pediatric and vascular access applications.<\/p>\n

\n About ENvue Medical, Inc.<\/strong>
\n
ENvue Medical, Inc. (NASDAQ: FEED) is a medical technology company specializing in the advancement of intelligent, non-invasive solutions for enteral care across clinical and home care settings. Headquartered in Tyler, Texas, with research and development in Tel-Aviv and Nesher, Israel, the Company focuses on two distinct technology platforms:<\/p>\n